FIELD: pharmaceutical chemistry; pharmacology.
SUBSTANCE: group of inventions relates to bromide derivative 1-(3,5-di-tert-butyl-4-hydroxybenzyl)indol-2-one-3-(4aR,4a1R,5aS,8aS,8a1S,15aS)-6-(2-hydrazino-2-oxoethyl)-10,11-dimethoxy-14-oxo-4a,4a1,5,5a,6,7,8,8a1,15,15a-decahydro-2H,14H-4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]-6-quinolinium of general formula Ia-c, as well as to the use of said compound as an agent having antiaggregatory activity.
EFFECT: wider range of biologically active substances exhibiting antiaggregatory activity.
2 cl, 1 dwg, 1 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT EXHIBITING ANTIAGGREGATORY ACTIVITY | 2019 |
|
RU2727508C1 |
| TRIAZOLE DERIVATIVES EXHIBITING ANTIAGGREGATORY ACTIVITY | 2021 |
|
RU2770405C1 |
| HYDROCHLORIDES OF 1-ALKYL-3-METHYL-8-PIPERAZINO-7-(TIETHANYL-3)XANTHINE SHOWING ANTITHROMBOTIC EFFECT BY BLOCKING GP IIb-IIIa PLATELETS RECEPTORS | 2017 |
|
RU2640579C1 |
| N'-PYRIDIN-4-YLMETHYLENE-2-[6-METHYL-4-(THIETAN-3-YLOXY)PYRIMIDIN-2-YLTHIO]ACETOHYDRAZIDE, HAVING ANTIAGGREGATION AND ANTICOAGULANT ACTIVITY | 2024 |
|
RU2825129C1 |
| USE OF 2,3,4-TRIMETHOXY-5-HYDROXY-9,10-DIHYDROPHENANTHRENE AS AN AGENT WITH ANTI-AGGREGATION ACTIVITY | 2023 |
|
RU2808460C1 |
| USE OF 5,7-DIHYDROXY-6,8-DIMETHYLFLAVANONE AS ANTI-AGGREGATION ACTIVITY | 2023 |
|
RU2812630C1 |
| USE OF 4-O-α-ARABINOFURANOSYLAGIC ACID AS ANTI-AGGREGATION ACTIVITY | 2023 |
|
RU2811240C1 |
| 3-N-DERIVATIVES OF 2 | 0 |
|
SU1796626A1 |
| METHOD AND INTERMEDIATES FOR HEPTAPEPTIDE PRODUCTION | 2006 |
|
RU2303603C2 |
| CYCLOHEXYLAMMONIUM SALT OF [3-METHYL-1-N-PROPYL-7-(1-OXOTHIETANYL-3)XANTHINYL-8-THIO]ACETIC ACID EXHIBITING ANTITHROMBOTIC ACTIVITY | 2011 |
|
RU2459826C1 |
